Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1675]

Report appraises bowel cancer care in England and Wales

Report appraises bowel cancer care in England and Wales

High impact radiopeptide therapy halts neuroendocrine cancer

High impact radiopeptide therapy halts neuroendocrine cancer

ASCO 2011: High-dose chemo regimen improves survival in children with hard-to-treat neuroblastoma

ASCO 2011: High-dose chemo regimen improves survival in children with hard-to-treat neuroblastoma

ASCO 2011: Three years of imatinib improves survival for high-risk gastrointestinal stromal tumours

ASCO 2011: Three years of imatinib improves survival for high-risk gastrointestinal stromal tumours

ASCO 2011: Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence

ASCO 2011: Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence

ASCO 2011: 'Driver' mutations identified for advanced lung cancer

ASCO 2011: 'Driver' mutations identified for advanced lung cancer

ASCO 2011: Adding regional nodal irradiation decreases recurrences in women with early breast cancer

ASCO 2011: Adding regional nodal irradiation decreases recurrences in women with early breast cancer

Lipofilling may be safe during conservation treatment for breast cancer

Lipofilling may be safe during conservation treatment for breast cancer

Access to personal medical records increases satisfaction among new cancer patients inn US

Access to personal medical records increases satisfaction among new cancer patients inn US

FDA approves Sutent for rare type of pancreatic cancer

FDA approves Sutent for rare type of pancreatic cancer

More from ecancer